NEW METASTASIS-SUPPRESSOR GENE
NEW METASTASIS-SUPPRESSOR GENE
批准号:
2414466
负责人:
Emma Shtivelman
金额:
$23.34万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-15 至 1998-04-30
关键词:
SCID mouse angiogenesis cell adhesion disease /disorder model gene expression human fetus tissue immunofluorescence technique immunoprecipitation metastasis model design /development neoplasm /cancer classification /staging neoplasm /cancer genetics neoplastic process oncoproteins posttranslational modifications prognosis protein structure function small cell lung cancer tumor suppressor genes
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (adapted from the investigator's abstract) Mechanisms of
metastatic spread of high aggressive tumors such as small cell lung cancer
(SCLC) are poorly understood. A unique SCID-hu metastasis model was
developed that for the first time allows metastasis of SCLC to be studied in
the experimental in vivo setting. Molecular analysis of SCLC cell lines
with different metastatic potentials have led to the identification of a
novel human gene designated CC3 whose expression is lacking in metastatic
cells. Introduction of CC3 into SCLC cells suppresses their ability to form
metastatic tumors in the SCID-hu mice. The goal of this project then is to
prove that CC3 is a metastasis suppressor gene in small cell lung cancer and
to analyze the mechanisms of metastasis suppression by CC3. The functional
relevance of the lack of expression of CC3 to the metastatic phenotype of
SCLC will be further confirmed in the in vivo metastasis assays. The
clinical relevance and potential prognostic significance of CC3 expression
will be evaluated through analysis of its expression in clinical tumor
specimens. The mechanism of metastasis-suppression by CC3 will be addressed
in experiments designed to define the effects of CC3 expression on the
phenotype of metastatic cells. These investigators anticipate that the
results of these studies will advance the understanding of the mechanisms of
metastasis of SCLC. Lack of CC3 protein could have prognostic significance
in patients diagnosed with SCLC and potentially other tumors. A thorough
understanding of CC3 function might eventually lead to the development of
new anti-metastatic therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Plant-Derived Estrogens and Cell Proliferation
-
批准号:7805677
-
项目类别:
-
资助金额:$17.42万
-
财政年份:2010
-
负责人:Emma Shtivelman
-
依托单位:
Plant-Derived Estrogens and Cell Proliferation
-
批准号:8258471
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2010
-
负责人:Emma Shtivelman
-
依托单位:
INHIBITION OF NUCLEAR TRANSPORT BY TUMOR SUPPRESSOR CC3
-
批准号:7460827
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2006
-
负责人:Emma Shtivelman
-
依托单位:
INHIBITION OF NUCLEAR TRANSPORT BY TUMOR SUPPRESSOR CC3
-
批准号:7140747
-
项目类别:
-
资助金额:$23.96万
-
财政年份:2006
-
负责人:Emma Shtivelman
-
依托单位:
INHIBITION OF NUCLEAR TRANSPORT BY TUMOR SUPPRESSOR CC3
-
批准号:7633147
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2006
-
负责人:Emma Shtivelman
-
依托单位:
INHIBITION OF NUCLEAR TRANSPORT BY TUMOR SUPPRESSOR CC3
-
批准号:7257229
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2006
-
负责人:Emma Shtivelman
-
依托单位:
NEW METASTASIS SUPPRESSOR GENE
-
批准号:2700684
-
项目类别:
-
资助金额:$24.28万
-
财政年份:1998
-
负责人:Emma Shtivelman
-
依托单位:
NEW METASTASIS-SUPPRESSOR GENE
-
批准号:2742610
-
项目类别:
-
资助金额:$24.85万
-
财政年份:1998
-
负责人:Emma Shtivelman
-
依托单位:
NEW METASTASIS-SUPPRESSOR GENE
-
批准号:2115051
-
项目类别:
-
资助金额:$22.45万
-
财政年份:1996
-
负责人:Emma Shtivelman
-
依托单位:
国内基金
海外基金
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位: